Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 28 Mar 2025

Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth

in Pharmacology of Anti-Cancer Drugs

Baoyi Jiang
Jie Yang
Qingtian Huang
Wei Li
Qian Peng
Huoye Gan
Tieli Peng
Leyi Yao
Ling Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547685

986 views

Review

Published on 28 Mar 2025

Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers

in Pharmacology of Anti-Cancer Drugs

Qingmei Ye
Xiao-Zhao Zhuang
Juan Li
Xin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562167

1,180 views

Original Research

Published on 27 Mar 2025

Enhancing survival outcomes in unresectable hepatocellular carcinoma: a prospective cohort study on the effects of Huaier granules with targeted therapy plus immunotherapy

in Pharmacology of Anti-Cancer Drugs

Hui Li
Hongliang Zhang
Wenting He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529010

877 views

Mini Review

Published on 27 Mar 2025

Molecular mechanisms and signaling pathways related to brain metastasis in breast cancer

in Pharmacology of Anti-Cancer Drugs

Zhuming Liang
Yanan Mo
Yujiao Zhang
Yanjing Yu
Yinan Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585668

1,681 views

Original Research

Published on 27 Mar 2025

The characteristics of adverse reactions of three anti-prostate cancer drugs based on Vigiaccess database and bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Jianqing Wang
Jia You
Weixing Huang
Chiting Yuan
Jiangjie Chen
Feifei Wang
Wei Wang
Liwei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570661

1,710 views

Review

Published on 27 Mar 2025

Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review

in Pharmacology of Anti-Cancer Drugs

Deena Elsori
Pratibha Pandey
Meenakshi Verma
Nasir Vadia
R. Roopashree
Manish Vyas
L. Lakshmi
Laxmidhar Maharana
Deepak Nathiya
Mohd Saeed

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579609

1,063 views

Review

Published on 26 Mar 2025

CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Yu Huang
Yulu Ye
Tingzhuang Yi
Cheng Yuan
Daojun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559558

2,549 views

Perspective

Published on 26 Mar 2025

Rethinking corticosteroids use in oncology

in Pharmacology of Anti-Cancer Drugs

Pierrick Martinez
Jean-Marc Sabatier

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551111

1,788 views

Original Research

Published on 25 Mar 2025

Screening and exploration of neoadjuvant “de-escalation” therapy for early breast cancer

in Pharmacology of Anti-Cancer Drugs

Nana Zhang
Ming Shan
Zhenfeng Huang
Fei Gao
Bingqi Xu
Wenli Kang
Jian Zhang
Li Song
Jun Liu
Jiawei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1574665

933 views

Original Research

Published on 25 Mar 2025

Milciclib-mediated CDK2 inhibition to boost radiotherapy sensitivity in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Junjie Ma
Shanshan Wu
Xinxin Yang
Shuying Shen
Yiqian Zhu
Ruoqi Wang
Wei Xu
Yue Li
Haixin Zhu
Youyou Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557925

1,107 views

Original Research

Published on 24 Mar 2025

Efficacy and safety of PD-1/PD-L1 inhibitors combined with tyrosine kinase inhibitors as first-line treatment for hepatocellular carcinoma: a meta-analysis and trial sequential analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Peng Tang
Fei Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535444

1,205 views

Original Research

Published on 21 Mar 2025

Identifying acute myeloid leukemia subtypes based on pathway enrichment

in Pharmacology of Anti-Cancer Drugs

Ling Zhong
Jiangti Luo
Junze Dong
Xiang Yang
Xiaosheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557112

1,201 views

Mini Review

Published on 21 Mar 2025

Circulating tumor DNA: a revolutionary approach for early detection and personalized treatment of bladder cancer

in Pharmacology of Anti-Cancer Drugs

Yan Zhou
Rongzhong Wang
Mingtang Zeng
Sijia Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551219

1,278 views

Case Report

Published on 21 Mar 2025

Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Minchun Chen
Jing Shen
Rongrong Jia
Mingze Chang
Jingyi Zhang
Jie Zheng
Runqing Xue
Lulu Guo
Kangkang Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1487009

814 views
1 citation

Original Research

Published on 21 Mar 2025

Crocin promotes ferroptosis in gastric cancer via the Nrf2/GGTLC2 pathway

in Pharmacology of Anti-Cancer Drugs

Nan Yan
Gaofu Li
Linglin Zhao
Qijing Guo
Jie Yang
Jianhong Liu
Wei Zhou
Yue Gao
Yushuang Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527481

1,509 views

Original Research

Published on 21 Mar 2025

Histidine-rich glycoprotein inhibits TNF-α–induced tube formation in human vascular endothelial cells

in Pharmacology of Anti-Cancer Drugs

Omer Faruk Hatipoglu
Takashi Nishinaka
Kursat Oguz Yaykasli
Shuji Mori
Masahiro Watanabe
Takao Toyomura
Masahiro Nishibori
Satoshi Hirohata
Hidenori Wake
Hideo Takahashi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561628

966 views